Document Detail

Prescribed dietary phosphate restriction and survival among hemodialysis patients.
MedLine Citation:
PMID:  21148246     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND OBJECTIVES: Hyperphosphatemia is common among hemodialysis patients. Although prescribed dietary phosphate restriction is a recommended therapy, little is known about the long-term effects on survival.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a post hoc analysis of data from the Hemodialysis Study (n = 1751). Prescribed dietary phosphate was recorded at baseline and annually thereafter. Marginal structural proportional hazard models were fit to estimate the adjusted association between dietary phosphate restriction and mortality in the setting of time-dependent confounding.
RESULTS: At baseline, prescribed daily phosphate was restricted to levels ≤ 870, 871 to 999, 1000, 1001 to 2000 mg, and not restricted in 300, 314, 307, 297, and 533 participants, respectively. More restrictive prescribed dietary phosphate was associated with poorer indices of nutritional status on baseline analyses and a persistently greater need for nutritional supplementation but not longitudinal changes in caloric or protein intake. On marginal structural analysis, there was a stepwise trend toward greater survival with more liberal phosphate prescription, which reached statistical significance among subjects prescribed 1001 to 2000 mg/d and those with no specified phosphate restriction: hazard ratios (95% CIs) 0.73 (0.54 to 0.97) and 0.71 (0.55 to 0.92), respectively. Subgroup analysis suggested a more pronounced survival benefit of liberal dietary phosphate prescription among nonblacks, participants without hyperphosphatemia, and those not receiving activated vitamin D.
CONCLUSIONS: Prescribed dietary phosphate restriction is not associated with improved survival among prevalent hemodialysis patients, and increased level of restriction may be associated with greater mortality particularly in some subgroups.
Katherine E Lynch; Rebecca Lynch; Gary C Curhan; Steven M Brunelli
Related Documents :
17720106 - Notes from the ckd kitchen: restaurant dining.
7414256 - Detection of hyperlipidemia by semiquantitative fluorometric determinations of serum li...
16303026 - Mortality patterns in infectious salmon anaemia virus outbreaks in new brunswick, canada.
10071176 - The risk of acute suicidality in psychiatric inpatients increases with low plasma chole...
3578556 - Polyunsaturated lipid diet lengthens torpor and reduces body temperature in a hibernator.
11517816 - Lipid management: tools for getting to the goal.
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-12-09
Journal Detail:
Title:  Clinical journal of the American Society of Nephrology : CJASN     Volume:  6     ISSN:  1555-905X     ISO Abbreviation:  Clin J Am Soc Nephrol     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-03-17     Completed Date:  2011-06-30     Revised Date:  2014-06-25    
Medline Journal Info:
Nlm Unique ID:  101271570     Medline TA:  Clin J Am Soc Nephrol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  620-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chi-Square Distribution
Hyperphosphatemia / diet therapy*,  etiology,  mortality
Kaplan-Meier Estimate
Linear Models
Logistic Models
Middle Aged
Nutritional Status
Phosphates / administration & dosage,  adverse effects*
Phosphorus, Dietary / administration & dosage,  adverse effects*
Proportional Hazards Models
Prospective Studies
Renal Dialysis / adverse effects,  mortality*
Risk Assessment
Risk Factors
Survival Rate
Time Factors
Treatment Outcome
United States / epidemiology
Grant Support
Reg. No./Substance:
0/Phosphates; 0/Phosphorus, Dietary

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  LC3A autophagic acivity and prognostic significance in non-small cell lung carcinomas.
Next Document:  Dialysis at a Crossroads: 50 Years Later.